Diabetes–New compounds may lower blood sugar but prevent weight gain
October 26, 2017
Source: medicalnewstoday
674
Insulin resistance is a known risk factor for type 2 diabetes. It arises when the body's cells are no longer able to respond to insulin, which is the hormone that regulates blood glucose.
As a result, blood glucose levels can become too high, and this may lead to type 2 diabetes. There are medications that can help to prevent the progression to type 2 diabetes in patients with insulin resistance, such as thiazolidinediones.
But unfortunately, these medications can promote weight gain and a number of other health problems.
Dr. Domenico Accili — director of the Columbia University Diabetes Research Center at Columbia University Medical Center in New York City, NY — and colleagues have identified a number of compounds that may be just as effective as current insulin resistance medications on the market, but which do not lead to weight gain.
The researchers recently reported their findings in the journal Cell.
Copyright©2024 Ddu. All rights reserved.
Read more on
- Things to Know before Buying Newborn Baby Incubators March 31, 2022
- Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients August 26, 2021
- Autoantibody order, timing predict genetically at-risk children most likely to get type 1 diabetes October 30, 2020
- Highly Resistant Food Poisoning Bug Responds to Antibiotics September 6, 2018
- Smartphone Based Diagnosis to Identify Mosquitoes Transmitting Infection September 5, 2018
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
